News Archive - COVID-19

Company Founded by Engineering Alumni Advances 1-hour COVID Test

Medical diagnostic company Fluxergy, founded by UC San Diego engineering alumni, submitted an Emergency Use Authorization to the FDA for their quick, point-of-care COVID-19 test.

Tested and Testing: UC San Diego Health Expands COVID-19 Diagnostics

UC San Diego Health makes measurable progress addressing COVID-19 testing shortage through multiple partnerships and rapidly growing in-house testing. Success has meant more testing for more patients, first responders and other health systems.

Bipartisan Coalition Urges U.S.-China Cooperation to Combat COVID-19

Over 90 bipartisan, high-level former government officials and experts in the U.S.-China relationship released a joint statement today urging cooperation between the United States and China in a much-needed effort to combat the COVID-19 global health crisis.

Qualcomm Institute Lends its Prototyping and 3D Printing Capabilities for Critical Medical Supplies

UC San Diego’s Qualcomm Institute is drawing on its unique range of expertise and technology to help in the rapid prototyping and development of medical supplies desperately needed in the fight against COVID-19.

Online Civic Design Challenge to Help San Diego Address COVID-19

Human-centered design can help San Diego address the COVID-19 pandemic and put our city on course to be more sustainable, too. That’s the basic premise of the 2020 edition of the city-wide design challenge from UC San Diego’s Design Lab called “Design for San Diego,” or D4SD for short.

New Studies Investigate How COVID-19 May Impact Breast Milk and Pregnancy

Researchers at University of California San Diego School of Medicine are launching a pair of studies to answer critical questions regarding the roles COVID-19 may play in breast milk and pregnancy.

UC San Diego Health Launches Clinical Trial to Assess Antiviral Drug for COVID-19

Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, a drug that has shown promising activity against multiple viruses.

UC San Diego Partners with 5 Leading Diagnostics Manufacturers to Boost COVID-19 Testing

Partnering with five diagnostics manufacturers, UC San Diego is significantly ramping up testing for COVID-19, projecting capacity to complete up to 1,500 tests daily within two to three weeks.

Disease Knows No Borders: UC to Address COVID-19 Impacts on U.S-Mexico Region

As the spread of COVID-19 has permeated communities around the world, experts from the University of California are looking at how to protect those most vulnerable along the U.S.-Mexico border.